methyl 17-((2R,3R,4S,5S,6R)-6-(acetoxymethyl)-3-((2S,3R,4S,5S,6R)-6-(acetoxymethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yloxy)-4,5-dihydroxytetrahydro-2H-pyran-2-yloxy)octadec-9-enoate

ID: ALA5207323

PubChem CID: 10818633

Max Phase: Preclinical

Molecular Formula: C35H60O15

Molecular Weight: 720.85

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)CCCCCCC/C=C\CCCCCCC(C)O[C@@H]1O[C@H](COC(C)=O)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](COC(C)=O)[C@@H](O)[C@H](O)[C@H]1O

Standard InChI:  InChI=1S/C35H60O15/c1-22(18-16-14-12-10-8-6-5-7-9-11-13-15-17-19-27(38)44-4)47-35-33(31(42)29(40)26(49-35)21-46-24(3)37)50-34-32(43)30(41)28(39)25(48-34)20-45-23(2)36/h5-6,22,25-26,28-35,39-43H,7-21H2,1-4H3/b6-5-/t22?,25-,26-,28-,29-,30+,31+,32-,33-,34+,35-/m1/s1

Standard InChI Key:  FLECYNVBJPYOEP-HVZMVQHPSA-N

Molfile:  

 
     RDKit          2D

 51 52  0  0  0  0  0  0  0  0999 V2000
   -4.9999    1.6495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2854    2.0620    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5709    1.6495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5709    0.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2854    0.4119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9999    0.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7141    2.0618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8567    2.0618    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8567    0.4120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2854   -0.4126    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7141    0.4120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4283    1.6495    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8567   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1424   -0.8248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5709   -0.8248    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5709   -1.6495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1424   -1.6495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2852   -2.0619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8567   -2.0619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4282   -0.4125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4282   -2.0619    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8567   -2.8866    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2852   -2.8866    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5709   -0.0001    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8567    2.8865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1424    3.2989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5709    3.2989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4282    2.8865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140    3.2989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0002    2.8865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7144    3.2989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4286    2.8865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1429    3.2989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8571    2.8865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8571    2.0618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5713    1.6495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5713    0.8247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2855    0.4123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2855   -0.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9997   -0.8246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9997   -1.6493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7140   -2.0616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7140   -2.8864    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4283   -1.6493    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9995   -3.2989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1427    2.0619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8572    1.6494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1428    2.8869    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9996   -3.2991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7141   -2.8865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9996   -4.1241    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  1  6  1  0
  6  5  1  0
  1  7  1  1
  3  8  1  1
  4  9  1  0
  5 10  1  1
  6 11  1  6
  7 12  1  0
 13  9  1  1
 13 14  1  0
 13 15  1  0
 15 16  1  0
 14 17  1  0
 16 18  1  1
 16 19  1  0
 17 19  1  0
 14 20  1  6
 17 21  1  1
 19 22  1  6
 18 23  1  0
  4 24  1  1
  8 25  1  0
 25 26  1  0
 25 27  1  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 44  2  0
 42 43  1  0
 43 45  1  0
 12 46  1  0
 46 47  1  0
 46 48  2  0
 23 49  1  0
 49 50  1  0
 49 51  2  0
M  END

Associated Targets(Human)

HPAC (93 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 720.85Molecular Weight (Monoisotopic): 720.3932AlogP: 1.96#Rotatable Bonds: 23
Polar Surface Area: 216.97Molecular Species: NEUTRALHBA: 15HBD: 5
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.09CX Basic pKa: CX LogP: 2.81CX LogD: 2.81
Aromatic Rings: Heavy Atoms: 50QED Weighted: 0.04Np Likeness Score: 1.38

References

1. Miceli RT, Corr DT, Barroso M, Dogra N, Gross RA..  (2022)  Sophorolipids: Anti-cancer activities and mechanisms.,  65  [PMID:35526504] [10.1016/j.bmc.2022.116787]

Source